Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rani Therapeutics Holdings, Inc. - Class A Common Stock (NQ: RANI )

1.569 +0.029 (+1.88%)
Streaming Delayed Price Updated: 11:34 AM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rani Therapeutics Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >
This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More
A game-changing pill from Rani Therapeutics may offer an easier alternative to fight debilitating diseases. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
48 Biggest Movers From Yesterday
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2021
Upgrades For Kite Realty Group Trust (NYSE: 
Via Benzinga
Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), an early s... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021
Upgrades Canaccord Genuity upgraded the previous rating for Precision Drilling Corp (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 71.92% to $5.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock increased by 25.72% to $2.59 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of... 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
Rani Therapeutics Holdings, Inc., a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq in its initial public offering. Rani shares opened for trading at $11.26. Since then,... 
Via Talk Markets
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
66 Biggest Movers From Yesterday
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI), a San Jose, California-based early stage biopharma, debuted Friday on the Nasdaq in its initial public offering. Rani Shares... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.